Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era

Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era

Human immunodeficiency virus (HIV) is a causative agent of acquired immune deficiency syndrome (AIDS). Highly active antiretroviral therapy (HAART) can slow down the replication of HIV-1, leading to an improvement in the survival of HIV-1-infected patients. However, drug toxicities and poor drug adm...

Full description

Bibliographic Details
Main Authors: Koollawat Chupradit, Sutpirat Moonmuang, Sawitree Nangola, Kuntida Kitidee, Umpa Yasamut, Marylène Mougel, Chatchai Tayapiwatana
Format: Article
Language:English
Published: MDPI AG 2017-09-01
Series:Viruses
Subjects:
HIV
HIV gene therapy
HIV vaccine
assembly inhibitor
entry inhibitor
fusion inhibitor
integration inhibitor
Online Access:https://www.mdpi.com/1999-4915/9/10/281

Internet

https://www.mdpi.com/1999-4915/9/10/281

Similar Items